Kratom-7 OH is emerging as a potent and addictive synthetic of kratom. Research suggests it presents similar risks as other ...

B7-H4-targeted immunotherapies offer market opportunities in developing treatments for cancers with high B7-H4 expression, including ovarian, breast, and endometrial cancers. Utilizing diverse ...

Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision ...

CD73 inhibitors offer significant market opportunities in cancer treatment through novel immunotherapies. Promising developments include monoclonal antibodies, nucleotides, and non-nucleotides, with ...

Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

Arrowhead Pharmaceuticals, Inc. ( ARWR) TD Cowen Treatment Advancements in Obesity and Related Disorders Summit November 24, 2025 1:30 PM EST ...

Q4 2025 Earnings Call Transcript November 25, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

About Flare Therapeutics Inc. Flare Therapeutics is a clinical-stage biotechnology company exclusively focused on drugging transcription factors to fully unlock the therapeutic potential of this ...

Research into Kisspeptin-10 has expanded well beyond its initial discovery as a metastasis suppressor fragment.

Researchers at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two receptors ...

The links between neurons are crucial to the brain, and brain cells can reorganize they way they are linked together in a ...